Fractyl Health, Inc. Common Stock (GUTS) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
GUTS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GUTS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | 46.2% | -100571.0% | -73864.5% |
| 2023 | 35.8% | -42363.3% | -64242.5% |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export GUTS earnings history in CSV or JSON format
Free sign-in required to download data
Fractyl Health, Inc. Common Stock (GUTS) Earnings Overview
As of May 8, 2026, Fractyl Health, Inc. Common Stock (GUTS) reported trailing twelve-month net income of -$97M, reflecting -14.8% year-over-year growth. The company earned $-1.86 per diluted share over the past four quarters.
Looking at the long-term picture, GUTS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$30M in fiscal 2020.
Fractyl Health, Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVAX (-$88M net income, 39.2% margin), ELVN (-$104M net income), RNAC (-$152M net income, -4658.6% margin), GUTS has comparable earnings metrics. Compare GUTS vs NVAX →
GUTS Earnings vs Peers
Earnings metrics vs comparable public companies
GUTS Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$141M | -105.2% | -$97M | $-1.86 | - | - |
| 2024 | -$69M | +10.9% | -$94M | $-1.62 | -73864.5% | -100571.0% |
| 2023 | -$77M | -66.0% | -$51M | $-1.98 | -64242.5% | -42363.3% |
| 2022 | -$46M | -19.9% | -$49M | $-1.34 | - | - |
| 2021 | -$39M | -27.1% | -$37M | $-1.12 | - | - |
| 2020 | -$30M | +0.4% | -$29M | $-0.86 | - | - |
| 2019 | -$31M | - | -$30M | $-0.64 | - | - |
See GUTS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GUTS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GUTS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGUTS — Frequently Asked Questions
Quick answers to the most common questions about buying GUTS stock.
Is GUTS growing earnings?
GUTS EPS fell to $-1.86, with earnings declining -14.8%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-97M.
What are GUTS's profit margins?
Fractyl Health, Inc. Common Stock net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are GUTS's earnings?
GUTS earnings data spans 2019-2025. The declining earnings trend is -14.8% YoY. Historical data enables comparison across business cycles.